Author (Year) |
|
Journal |
|
Title |
|
Is the study eligible? |
Yes |
No |
Maybe |
Note |
Type of study |
RCT? |
|
|
|
|
Not quasi‐RCT? |
|
|
|
|
Not cross‐over study? |
|
|
|
|
Not retracted study (see clinicaltrials.gov) or authored by Fujii and colleagues? |
|
|
|
|
Not abstract only? |
|
|
|
|
Types of participants |
Adults (≥ 18 years)? |
|
|
|
|
General anaesthesia? |
|
|
|
|
Types of intervention |
Monotherapy, or |
|
|
|
|
augmentation study (different class), or |
|
|
|
|
combination study (same class)? |
|
|
|
|
Substance class(es): |
Name of drug(s):__________________________________________ |
‐ 5‐HT₃ receptor antagonists |
|
|
|
|
‐ D₂ receptor antagonists |
|
|
|
|
‐ NK₁ receptor antagonists |
|
|
|
|
‐ Corticosteroids |
|
|
|
|
‐ Antihistamines |
|
|
|
|
‐ Anticholinergics |
|
|
|
|
Drug allocated before onset of PONV? |
|
|
|
|
Similar baseline anaesthesia regimen in study's arms? |
|
|
|
|
Outcomes of interest |
Outcomes of interest reported? |
|
|
|
|